Last edition
News about "Duvakitug Ulcerative Colitis treatment"
Teva and Sanofi Report Long-Term Data for Duvakitug
Teva and Sanofi have reported positive phase 2b data for duvakitug, showing sustained clinical remission and response in Ulcerative Colitis and Crohn’s Disease.
Duvakitug Ulcerative Colitis Treatment | 23/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members